CorMedix (CRMD) Gross Profit (2013 - 2025)

CorMedix (CRMD) has 12 years of Gross Profit data on file, last reported at $107.3 million in Q4 2025.

• For the quarter ending Q4 2025, Gross Profit rose 257.28% year-over-year to $107.3 million; the trailing twelve-month figure through Dec 2025 stood at $275.7 million (up 584.54% YoY), and the FY2025 full-year result was $275.7 million, up 584.54% from the prior year.
• Gross Profit grew to $107.3 million in Q4 2025, from $93.1 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $107.3 million in Q4 2025 to a low of -$818539.0 in Q1 2024.
• A 4-year average of $19.8 million and a median of $28109.0 in 2021 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit slumped 127.47% in 2021 and soared 12683.29% in 2025, its largest moves.
• Tracing CRMD's Gross Profit over 4 years: stood at $8390.0 in 2021, then jumped by 249.18% to $29296.0 in 2022, then surged by 102421.64% to $30.0 million in 2024, then jumped by 257.28% to $107.3 million in 2025.
• Business Quant data shows CRMD's Gross Profit at $107.3 million in Q4 2025, $93.1 million in Q3 2025, and $37.9 million in Q2 2025.